Prevention of Bacteremia Induced by Debridement of Pressure Ulcer - Full Text View

Prevention of Bacteremia Induced by Debridement of Pressure Ulcer

This study has been terminated.

Sponsored by:	Herzog Hospital
Information provided by:	Herzog Hospital
ClinicalTrials.gov Identifier:	NCT00269100

Purpose

The purpose of this study is to analyse bacteremia induced by debridement of pressure ulcers in patients in the complex nursing department.

Condition	Phase
Pressure Ulcers Bacteremia	Phase I Phase II

MedlinePlus related topics:

Pressure Sores

U.S. FDA Resources

Study Type:	Observational
Study Design:	Screening, Longitudinal, Defined Population, Prospective Study

Further study details as provided by Herzog Hospital:

Estimated Enrollment:

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Exclusion Criteria:

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00269100

Locations

Sponsors and Collaborators

Herzog Hospital

Investigators


Study Director:	Efraim Jaul	Herzog Hospital

More Information

Study ID Numbers:	Jaul1CTIL
First Received:	December 22, 2005
Last Updated:	April 19, 2007
ClinicalTrials.gov Identifier:	NCT00269100
Health Authority:	Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Herzog Hospital:

Debridement

Study placed in the following topic categories:

Systemic Inflammatory Response Syndrome

Bacterial Infections

Sepsis

Skin Diseases

Ulcer

Bacteremia

Skin Ulcer

Pressure Ulcer

Inflammation

Additional relevant MeSH terms:

Pathologic Processes

Infection

ClinicalTrials.gov processed this record on August 20, 2008